XML 21 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Investments
6 Months Ended
Jun. 30, 2018
Investments, Debt and Equity Securities [Abstract]  
Investments
NOTE 6. INVESTMENTS

The following tables summarize the Company’s available-for-sale investments at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,682

$

$

$
13,682

U.S. Treasury securities
31,850

1

(107
)
31,744

U.S. Agency securities
7,013


(69
)
6,944

Commercial paper
35,917



35,917

Asset-backed securities
8,992

2

(1
)
8,993

Corporate notes and bonds
33,388

1

(75
)
33,314

Total
$
130,842

$
4

$
(252
)
$
130,594


 
December 31, 2017
 
Amortized
Cost
Gross
Unrealized
Gains
Gross
Unrealized
Losses
Fair Value
Certificates of deposit
$
13,441

$

$

$
13,441

U.S. Treasury securities
14,787


(71
)
14,716

U.S. Agency securities
8,510


(51
)
8,459

Commercial paper
9,171



9,171

Asset-backed securities
3,026


(1
)
3,025

Corporate notes and bonds
31,906


(70
)
31,836

Total
$
80,841

$

$
(193
)
$
80,648



The following table summarizes the maturities of the Company’s available-for-sale securities at June 30, 2018 and December 31, 2017 (in thousands):

 
June 30, 2018
December 31, 2017
 
Amortized
Cost
Fair Value
Amortized
Cost
Fair Value
Due in less than 1 year
$
95,448

$
95,312

$
55,801

$
55,735

Due in 1-5 years
35,394

35,282

25,040

24,913

Total
$
130,842

$
130,594

$
80,841

$
80,648



Proceeds from sales of marketable securities (including principal paydowns), for the three months ended June 30, 2018 and 2017 were $0 and $6.5 million, respectively, and for the six months ended June 30, 2018 and 2017 were $3.0 million and $6.5 million, respectively. The Company determines gains and losses of marketable securities based on specific identification of the securities sold. There were no realized gains from sales of marketable securities for the three and six months June 30, 2018 and 2017. No balances were reclassified out of accumulated other comprehensive income (loss) for the three and six months June 30, 2018 and 2017.

No other-than-temporary impairments are recorded as no material investments had a fair value that remained less than its cost for more than twelve months as of those dates. The Company does not intend to sell investments and it is more likely than not that we will not be required to sell investments before recovering the amortized cost.